» » »

Transplant for Metabolic Disorders Chico CA

U.S. researchers are testing a new approach in cord-blood transplants to treat genetic metabolic disorders in babies while they're still in the womb. The new method uses a small, select number of therapeutic stem cells that have been treated to speed and improve engraftment (acceptance of the transplant by the body), explained Dr. Joanne Kurtzberg, a professor of pediatrics and pathology and director of the pediatric blood and marrow transplant program at Duke University Medical Center in Durham, N.C.

Jimmy Lewis Roberts, MD
(530) 892-2300
PO Box 6789
Chico, CA
Specialties
Nephrology, Immunology
Gender
Male
Education
Medical School: Univ Of Ca, Irvine, Ca Coll Of Med, Irvine Ca 92717
Graduation Year: 1970

Data Provided by:
Gary A Incaudo
(530) 896-2200
145 Mission Ranch Blvd
Chico, CA
Specialty
Allergy / Immunology, Pediatrics

Data Provided by:
Lenore Gretchen Wooding, MD
(530) 566-9461
254 Cohasset Rd # 10
Chico, CA
Specialties
Allergy & Immunology
Gender
Female
Education
Medical School: Univ Of Ca, San Diego, Sch Of Med, La Jolla Ca 92093
Graduation Year: 1976

Data Provided by:
James Eric Nagel, MD
(410) 558-8181
1560 Humboldt Rd
Chico, CA
Specialties
Allergy & Immunology
Gender
Male
Education
Medical School: Univ Of Il Coll Of Med, Chicago Il 60680
Graduation Year: 1970

Data Provided by:
Lenore Gretchen Wooding
(530) 893-9244
254 Cohasset Rd
Chico, CA
Specialty
Allergy / Immunology

Data Provided by:
Patricia Takach, MD
(530) 896-2200
145 Mission Ranch Blvd # 110
Chico, CA
Specialties
Allergy & Immunology
Gender
Male
Education
Graduation Year: 2007

Data Provided by:
Gary Arnold Incaudo, MD
(530) 896-2200
145 Mission Ranch Blvd # 110
Chico, CA
Specialties
Allergy & Immunology
Gender
Male
Education
Medical School: Univ Of Ca, Irvine, Ca Coll Of Med, Irvine Ca 92717
Graduation Year: 1971

Data Provided by:
Norman Donald Mc Cann, MD
(530) 891-4811
669 Palmetto Ave Ste I
Chico, CA
Specialties
Allergy & Immunology
Gender
Male
Education
Medical School: Univ Of Southern Ca Sch Of Med, Los Angeles Ca 90033
Graduation Year: 1967

Data Provided by:
Rahmatollah Afrasiabi, MD
(530) 896-7450
251 Cohasset Rd Ste 310
Chico, CA
Specialties
Allergy & Immunology
Gender
Male
Education
Medical School: Shiraz Univ Of Med Sci, Shiraz, Iran
Graduation Year: 1977

Data Provided by:
Norman D McCann
(530) 891-4811
669 Palmetto Ave
Chico, CA
Specialty
Allergy / Immunology

Data Provided by:
Data Provided by:

Transplant for Metabolic Disorders

Provided By:

FRIDAY, Oct. 16 (HealthDay News) -- U.S. researchers are testing a new approach in cord-blood transplants to treat genetic metabolic disorders in babies while they're still in the womb.

The new method uses a small, select number of therapeutic stem cells that have been treated to speed and improve engraftment (acceptance of the transplant by the body), explained Dr. Joanne Kurtzberg, a professor of pediatrics and pathology and director of the pediatric blood and marrow transplant program at Duke University Medical Center in Durham, N.C.

She and her team are studying the new procedure in a pilot trial open to pregnant women at risk for having children with fatal metabolic disorders, including Krabbe disease, metachromatic leukodystrophy, Pelizaeus-Maerzbacher disease, Tay-Sachs disease and Sandoff disease.

If untreated, these metabolic disorders can lead to bone, brain and central nervous system problems, and early death, the study authors noted in a Duke news release.

Donor cells used in the study will be made by the biopharmaceutical company Aldagen, Inc, which is a partner in the trial.

In many cases, cord-blood transplants after birth have proven successful in treating inherited metabolic disorders. Transplant timing is critical, Kurtzberg stressed.

"The idea is to give the baby cord-blood stem cells from a healthy donor that have the potential to provide healthy genes that can replace the ones that aren't working properly in the baby's own cells," Kurtzberg said in the news release.

In general, the earlier the transplant, the more likely it will work. That means that performing the transplant before the baby is born is ideal, she explained.

During the procedure, donor cells are injected directly into the fetus's abdomen at 12 to 14 weeks' pregnancy. At birth, the baby will be tested to see if the donor cells are present, and if they're fixing the malfunctioning genes. If not, the baby would be eligible for conventional cord-blood stem cell transplant within a few weeks.

More information

The Nemours Foundation has more about metabolism and metabolic disorders.

SOURCE: Duke Medicine, news release, Oct. 13, 2009

Copyright © 2009 ScoutNews, LLC. All rights reserved.

Read Article at HealthDay.com